ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

September 1, 1989